Article
HIF1α inhibition by dual targeting of CDK4/6 and HSP90 reduces cancer cell viability…
medRxiv · 2020 · Shuai Zhao
Key facts
| Title | HIF1α inhibition by dual targeting of CDK4/6 and HSP90 reduces cancer cell viability including Rb-deficient cells |
|---|---|
| First author | Shuai Zhao |
| Journal | medRxiv |
| Published | Oct 20, 2020 |
| DOI | 10.1101/2020.10.20.347633 |
| Devices mentioned | BK110039, K103302, K802418 |
| Product codes mentioned | KIP, KIT, MVU, NDS, NJT, OOI, KIS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1